- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, May 1, 2020
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An op-ed for The Center Square cited a study published in the August 2019 issue of The American Journal of Managed Care® (AJMC®). The study, “Influence of Out-of-Network Payment Standards on Insurer—Provider Bargaining: California’s Experience,” examined California’s experience implementing a policy to address surprise medical billing, which demonstrated that out-of-network payment standards can influence payer—provider bargaining leverage, affecting prices and network breadth.
A piece published by Pharmacy Times, titled “Study Finds VA Education Program Improves Quality of Care for Older Veterans,” referenced a study published in the September 2019 issue of AJMC®, “VA Geriatric Scholars Program’s Impact on Prescribing Potentially Inappropriate Medications.” The study highlighted how primary care teams reduced their prescribing of potentially inappropriate medications to older veterans after participation in the Veterans Affairs Geriatric Scholars Program.
A news item from The University of Kansas Cancer Center highlighted a peer-exchange series hosted by AJMC® titled “Expanding Treatment Options for Metastatic Breast Cancer.” The peer-to-peer panel discussion provides a review of the systemic treatment of metastatic breast cancers and the impact of recent clinical trial data on clinical decision making.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
FDA Approves Danziten for Chronic Myeloid Leukemia Without Mealtime Restrictions
November 14th 2024The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase inhibitor for chronic myeloid leukemia that can be taken without mealtime restrictions.
Read More
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
